Oxygen sensing by HIF hydroxylases

[1]  G. Booker,et al.  Substrate Requirements of the Oxygen-sensing Asparaginyl Hydroxylase Factor-inhibiting Hypoxia-inducible Factor* , 2004, Journal of Biological Chemistry.

[2]  K. Kivirikko,et al.  Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases* , 2004, Journal of Biological Chemistry.

[3]  David R. Jones,et al.  Role of Iron (II)-2-Oxoglutarate-dependent Dioxygenases in the Generation of Hypoxia-induced Phosphatidic Acid through HIF-1/2 and von Hippel-Lindau-independent Mechanisms* , 2004, Journal of Biological Chemistry.

[4]  Varda Rotter,et al.  Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. , 2003, Cancer research.

[5]  Thilo Hagen,et al.  Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α , 2003, Science.

[6]  L. del Peso,et al.  The von Hippel Lindau/Hypoxia-inducible Factor (HIF) Pathway Regulates the Transcription of the HIF-Proline Hydroxylase Genes in Response to Low Oxygen* , 2003, Journal of Biological Chemistry.

[7]  M. L. Rawlins,et al.  Oxygen and Iron Regulation of Iron Regulatory Protein 2* , 2003, Journal of Biological Chemistry.

[8]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[9]  P. Ratcliffe,et al.  2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. , 2003, Bioorganic & medicinal chemistry letters.

[10]  J. Pouysségur,et al.  HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.

[11]  K. Kivirikko,et al.  Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.

[12]  B. Brüne,et al.  Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. , 2003, Molecular biology of the cell.

[13]  P. Ratcliffe,et al.  HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels , 2003, Journal of Cell Science.

[14]  Rongfeng Li,et al.  Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-proline. , 2003, Journal of the American Chemical Society.

[15]  Maya Topf,et al.  Crystal Structure of Carbapenem Synthase (CarC)* , 2003, Journal of Biological Chemistry.

[16]  K. Eckardt,et al.  Activation of the hypoxia‐inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  L. Huang,et al.  Hypoxia-inducible Factor and Its Biomedical Relevance* , 2003, Journal of Biological Chemistry.

[18]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[19]  Carsten Krebs,et al.  The first direct characterization of a high-valent iron intermediate in the reaction of an alpha-ketoglutarate-dependent dioxygenase: a high-spin FeIV complex in taurine/alpha-ketoglutarate dioxygenase (TauD) from Escherichia coli. , 2003, Biochemistry.

[20]  George M. Hilliard,et al.  Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α* , 2003, The Journal of Biological Chemistry.

[21]  P. Ratcliffe,et al.  Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. , 2003, Bioorganic & medicinal chemistry letters.

[22]  A. Harris,et al.  Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. , 2003, Cancer research.

[23]  J. Klco,et al.  Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. , 2003, Molecular cancer research : MCR.

[24]  C. Schofield,et al.  The Selectivity and Inhibition of AlkB* , 2003, The Journal of Biological Chemistry.

[25]  Seong Eon Ryu,et al.  Structure of Human FIH-1 Reveals a Unique Active Site Pocket and Interaction Sites for HIF-1 and von Hippel-Lindau* , 2003, The Journal of Biological Chemistry.

[26]  R. Conaway,et al.  von Hippel–Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Magnar Bjørås,et al.  Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA , 2003, Nature.

[28]  Mi Hee Lim,et al.  Crystallographic and spectroscopic characterization of a nonheme Fe(IV)-O complex. , 2003, Science.

[29]  Robert P. Hausinger,et al.  O2- and α-Ketoglutarate-Dependent Tyrosyl Radical Formation in TauD, an α-Keto Acid-Dependent Non-Heme Iron Dioxygenase† , 2003 .

[30]  R. Conaway,et al.  Multiple Splice Variants of the Human HIF-3α Locus Are Targets of the von Hippel-Lindau E3 Ubiquitin Ligase Complex* , 2003, The Journal of Biological Chemistry.

[31]  J. Elkins,et al.  Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1α* , 2003, The Journal of Biological Chemistry.

[32]  J. Deisenhofer,et al.  Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Huang,et al.  Leu-574 of HIF-1α Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway* , 2002, The Journal of Biological Chemistry.

[34]  C. Schofield,et al.  Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. , 2002, The Biochemical journal.

[35]  P. Sutphin,et al.  Role of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α* , 2002, The Journal of Biological Chemistry.

[36]  D. Richardson,et al.  The role of iron in cell cycle progression and the proliferation of neoplastic cells. , 2002, Biochimica et biophysica acta.

[37]  Lázaro Centanin,et al.  Control of the Hypoxic Response in Drosophila melanogaster by the Basic Helix-Loop-Helix PAS Protein Similar , 2002, Molecular and Cellular Biology.

[38]  Mircea Ivan,et al.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Erling Seeberg,et al.  AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli , 2002, Nature.

[40]  Robert P. Hausinger,et al.  Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage , 2002, Nature.

[41]  B. Baysal.  Hereditary paraganglioma targets diverse paraganglia , 2002, Journal of medical genetics.

[42]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Y. Fujii‐Kuriyama,et al.  HIF-1α-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway , 2002 .

[44]  Christopher J Schofield,et al.  Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.

[45]  Y. Fujii‐Kuriyama,et al.  The Transcriptional Activation Function of the HIF-like Factor Requires Phosphorylation at a Conserved Threonine* , 2002, The Journal of Biological Chemistry.

[46]  Christopher J. Schofield,et al.  Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL , 2002, Nature.

[47]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[48]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[49]  Christopher J Schofield,et al.  Crystal structure of a clavaminate synthase–Fe(II)–2‐oxoglutarate–substrate–NO complex: evidence for metal centred rearrangements , 2002, FEBS letters.

[50]  H. Dyson,et al.  Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Livingston,et al.  Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[53]  Kai-Uwe Eckardt,et al.  Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. , 2002, Journal of the American Society of Nephrology : JASN.

[54]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[55]  G. Semenza.  Involvement of hypoxia-inducible factor 1 in human cancer. , 2002, Internal medicine.

[56]  K. Polyak,et al.  Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression) , 2002, Oncogene.

[57]  P. Ratcliffe,et al.  Expression of Hypoxia-Inducible Factor-1 (cid:1) and -2 (cid:1) in Hypoxic and Ischemic Rat Kidneys , 2002 .

[58]  C. Schofield,et al.  Structure and mechanism of anthocyanidin synthase from Arabidopsis thaliana. , 2002, Structure.

[59]  M. Taubman,et al.  Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[60]  J. Dunwell,et al.  Evolution of functional diversity in the cupin superfamily. , 2001, Trends in biochemical sciences.

[61]  Yuichi Makino,et al.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.

[62]  B. Brüne,et al.  Regulation of the Hypoxia-inducible Factor 1α by the Inflammatory Mediators Nitric Oxide and Tumor Necrosis Factor-α in Contrast to Desferroxamine and Phenylarsine Oxide* , 2001, The Journal of Biological Chemistry.

[63]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[64]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[65]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[66]  T. Bugg.  Oxygenases: mechanisms and structural motifs for O(2) activation. , 2001, Current opinion in chemical biology.

[67]  P. Ratcliffe,et al.  Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.

[68]  S. White,et al.  HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  C. Townsend,et al.  Spectroscopic studies of substrate interactions with clavaminate synthase 2, a multifunctional alpha-KG-dependent non-heme iron enzyme: correlation with mechanisms and reactivities. , 2001, Journal of the American Chemical Society.

[70]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[71]  P. Ratcliffe,et al.  Activation of the HIF pathway in cancer. , 2001, Current opinion in genetics & development.

[72]  M. D. Lloyd,et al.  Alteration of the Co-substrate Selectivity of Deacetoxycephalosporin C Synthase , 2001, The Journal of Biological Chemistry.

[73]  M. D. Lloyd,et al.  Kinetic and crystallographic studies on deacetoxycephalosporin C synthase (DAOCS). , 2001, Journal of molecular biology.

[74]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[75]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[76]  J. Pouysségur,et al.  HIF‐1‐dependent transcriptional activity is required for oxygen‐mediated HIF‐1α degradation , 2001, FEBS letters.

[77]  R. Freeman,et al.  SM-20 Is a Novel Mitochondrial Protein That Causes Caspase-dependent Cell Death in Nerve Growth Factor-dependent Neurons* , 2001, The Journal of Biological Chemistry.

[78]  C. Ponting,et al.  JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. , 2001, Trends in biochemical sciences.

[79]  Eugene V Koonin,et al.  The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases , 2001, Genome Biology.

[80]  A. Harris,et al.  Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling , 2000, Oncogene.

[81]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[82]  S. Ferdinandusse,et al.  Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease. , 2000, Human molecular genetics.

[83]  A. Koong,et al.  Candidate genes for the hypoxic tumor phenotype. , 2000, Cancer research.

[84]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[85]  Christopher J. Schofield,et al.  Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase , 2000, Nature Structural Biology.

[86]  M. Makuuchi,et al.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.

[87]  C. Schofield,et al.  Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. , 1999, Current opinion in structural biology.

[88]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[89]  M. Goldberg,et al.  Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide , 1999, The Journal of Biological Chemistry.

[90]  K. Kivirikko,et al.  Mechanism-Based Inactivation of the Human Prolyl-4-hydroxylase by 5-Oxaproline-Containing Peptides: Evidence for a Prolyl Radical Intermediate , 1999 .

[91]  M. D. Lloyd,et al.  Structure of a cephalosporin synthase , 1998, Nature.

[92]  Y. Fujii‐Kuriyama,et al.  Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[93]  K. Kivirikko,et al.  Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[94]  C. Townsend,et al.  Circular Dichroism and Magnetic Circular Dichroism Spectroscopic Studies of the Non-Heme Ferrous Active Site in Clavaminate Synthase and Its Interaction with α-Ketoglutarate Cosubstrate , 1998 .

[95]  L. Que,et al.  The 2-His-1-carboxylate facial triad--an emerging structural motif in mononuclear non-heme iron(II) enzymes. , 1997, European journal of biochemistry.

[96]  C. Schofield,et al.  Inactivation of 1-aminocyclopropane-1-carboxylate oxidase involves oxidative modifications. , 1997, Biochemistry.

[97]  K. Kivirikko,et al.  Characterization of the iron‐ and 2‐oxoglutarate‐binding sites of human prolyl 4‐hydroxylase , 1997, EMBO Journal.

[98]  S. Madden,et al.  Induction of cell growth regulatory genes by p53. , 1996, Cancer research.

[99]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.

[100]  J. Wands,et al.  Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. , 1996, The Journal of clinical investigation.

[101]  Geoffrey J. Barton,et al.  Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes , 1995, Nature.

[102]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[103]  M. Taubman,et al.  Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. , 1994, The Journal of biological chemistry.

[104]  P. Ratcliffe,et al.  Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[105]  J. Fandrey,et al.  In Vivo and In Vitro Regulation of Erythropoietin mRNA: Measurement by Competitive Polymerase Chain Reaction , 1993 .

[106]  J. Fandrey,et al.  In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. , 1993, Blood.

[107]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[108]  K. Kivirikko,et al.  Protein hydroxylation: prolyl 4‐hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  K. Majamaa,et al.  Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. , 1984, The Journal of biological chemistry.

[110]  A. Bach.  [Carnitine biosynthesis in mammals]. , 1982, Reproduction, nutrition, developpement.